FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37260574> ?p ?o ?g. }

• Q37260574 description "article científic" @default.
• Q37260574 description "article scientifique" @default.
• Q37260574 description "articolo scientifico" @default.
• Q37260574 description "artigo científico" @default.
• Q37260574 description "artículu científicu espublizáu en 2011" @default.
• Q37260574 description "bilimsel makale" @default.
• Q37260574 description "scientific article published on 15 October 2011" @default.
• Q37260574 description "vedecký článok" @default.
• Q37260574 description "vetenskaplig artikel" @default.
• Q37260574 description "videnskabelig artikel" @default.
• Q37260574 description "vědecký článek" @default.
• Q37260574 description "wetenschappelijk artikel" @default.
• Q37260574 description "wissenschaftlicher Artikel" @default.
• Q37260574 description "наукова стаття, опублікована в жовтні 2011" @default.
• Q37260574 description "научни чланак" @default.
• Q37260574 description "مقالة علمية نشرت في 15 أكتوبر 2011" @default.
• Q37260574 name "CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma" @default.
• Q37260574 name "CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma" @default.
• Q37260574 name "CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma." @default.
• Q37260574 type Item @default.
• Q37260574 label "CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma" @default.
• Q37260574 label "CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma" @default.
• Q37260574 label "CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma." @default.
• Q37260574 prefLabel "CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma" @default.
• Q37260574 prefLabel "CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma" @default.
• Q37260574 prefLabel "CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma." @default.
• Q37260574 P1433 Q37260574-757FD656-72E5-42B6-B24E-3E58A597EF9A @default.
• Q37260574 P1476 Q37260574-826D1103-3B9E-4611-B1E5-7244D33CD2C9 @default.
• Q37260574 P2093 Q37260574-5985B000-198D-4007-B9F2-1255519598F2 @default.
• Q37260574 P2093 Q37260574-65F863DA-40B7-42D9-BD65-913E1DF3CF52 @default.
• Q37260574 P2093 Q37260574-9CB024FB-EA11-4B61-9383-D39800386E56 @default.
• Q37260574 P2093 Q37260574-D32BC52B-5E3F-4955-AA57-9E05EB06D2E1 @default.
• Q37260574 P2093 Q37260574-D4D8FAE4-8B36-4FB7-91AD-5DB12BD6FE16 @default.
• Q37260574 P2093 Q37260574-DB2C437F-464C-4197-9A64-87319AA1F7DD @default.
• Q37260574 P2093 Q37260574-E4CE1F2B-D2C9-4C8A-8148-C16FFC5C9241 @default.
• Q37260574 P2860 Q37260574-0436D6D8-8390-41E3-B62E-D2E8A2691EC0 @default.
• Q37260574 P2860 Q37260574-09B9C09F-8F6C-4CEF-8895-37EF2B813F59 @default.
• Q37260574 P2860 Q37260574-1104A749-9152-454B-B3F5-B64494414866 @default.
• Q37260574 P2860 Q37260574-1A9B072C-1108-4703-B7D2-9F858136EDBD @default.
• Q37260574 P2860 Q37260574-204BD19C-0E19-48E9-A9A5-012110665CE6 @default.
• Q37260574 P2860 Q37260574-23F4443A-6E64-4B29-9703-8E06BEDA60A5 @default.
• Q37260574 P2860 Q37260574-26FE8104-5C48-4CA7-A757-78A162D86661 @default.
• Q37260574 P2860 Q37260574-40E77243-E617-4EDB-AFAC-06375ACD33A9 @default.
• Q37260574 P2860 Q37260574-42B3E6DB-8AA9-4DF8-B4F4-740ED1F3CD72 @default.
• Q37260574 P2860 Q37260574-43B97D91-EB33-445C-BCEE-7F0E04480C92 @default.
• Q37260574 P2860 Q37260574-45264D9B-12FA-40A9-AA06-F1A9CCCD14B9 @default.
• Q37260574 P2860 Q37260574-46B6FD4C-0550-4528-B473-F1F1F7933548 @default.
• Q37260574 P2860 Q37260574-492439C7-DA99-4FFC-84CE-4AB7ECED3E00 @default.
• Q37260574 P2860 Q37260574-5153A480-7D6E-436D-8104-28B9069C3319 @default.
• Q37260574 P2860 Q37260574-5A7FC649-064D-411F-9E51-A56CC4A11B49 @default.
• Q37260574 P2860 Q37260574-5B15F81C-E1B5-41A9-A264-288E6015394A @default.
• Q37260574 P2860 Q37260574-62DBB070-E405-4795-8955-2B79EAD9D31B @default.
• Q37260574 P2860 Q37260574-6AE235BD-F954-4FB0-8151-257453FBC940 @default.
• Q37260574 P2860 Q37260574-6C0102EA-5F23-4C0A-ACBC-725866FEF3DC @default.
• Q37260574 P2860 Q37260574-6D31529C-F738-4A8F-8BC2-719D943EC6BC @default.
• Q37260574 P2860 Q37260574-724A0845-BFBF-48D3-B9D9-D67CE714072F @default.
• Q37260574 P2860 Q37260574-7AB4FEB0-9F42-411F-893F-58058865B276 @default.
• Q37260574 P2860 Q37260574-7D140589-69FC-444F-AC14-509B54CCA464 @default.
• Q37260574 P2860 Q37260574-7F07A11A-DCB9-4BA6-B785-A1007B8738E3 @default.
• Q37260574 P2860 Q37260574-80CA358C-1F46-479D-85CB-180FE0744397 @default.
• Q37260574 P2860 Q37260574-82164A60-B315-4F54-A1A7-4AFCEC246897 @default.
• Q37260574 P2860 Q37260574-845BD771-85BE-4161-8A34-C928AFD85A45 @default.
• Q37260574 P2860 Q37260574-8B8FD450-8C3B-4052-8899-04A9EA8D91DE @default.
• Q37260574 P2860 Q37260574-8F1A3023-241C-4960-8059-3C91BE621896 @default.
• Q37260574 P2860 Q37260574-B0746CA0-F685-48F7-9F27-2D500286ADEA @default.
• Q37260574 P2860 Q37260574-BFBFFFAF-9A45-4CF4-8C23-51215DAB77DA @default.
• Q37260574 P2860 Q37260574-C087170D-0B67-4C32-AF14-3CD995E459D4 @default.
• Q37260574 P2860 Q37260574-C402ACC5-B5B9-4A5C-8390-7C46ACAAF413 @default.
• Q37260574 P2860 Q37260574-C4FF147C-59D1-4F8E-A1EA-37EB9EACCDAE @default.
• Q37260574 P2860 Q37260574-C969FC82-C288-4429-8B1E-85B80F454993 @default.
• Q37260574 P2860 Q37260574-C976018A-ED1A-4F41-BFB1-5384E6129594 @default.
• Q37260574 P2860 Q37260574-CAAE6E79-E6F9-42C5-B258-84524D049CAF @default.
• Q37260574 P2860 Q37260574-CDDB682A-A357-4290-B6A2-ED32A75EB12C @default.
• Q37260574 P2860 Q37260574-CDEF9E1C-4E2A-4776-959F-A5639DA83E4D @default.
• Q37260574 P2860 Q37260574-D2F17F3A-14AE-4605-8270-D222F2B86E7A @default.
• Q37260574 P2860 Q37260574-E4B96945-AC58-4E7D-8003-D69EBB8877BE @default.
• Q37260574 P2860 Q37260574-E6EC316E-ED8B-4719-A842-18442552B5B3 @default.
• Q37260574 P2860 Q37260574-ED7ED382-B2E0-4F09-B34F-14F313516A1B @default.
• Q37260574 P2860 Q37260574-FAA3AAC8-72F1-4C65-A604-BDAC65BE9D5A @default.
• Q37260574 P2888 Q37260574-B2F60465-2273-4077-B469-0B57A0A0F9DF @default.
• Q37260574 P304 Q37260574-8D86755F-40A7-41EE-B95B-5337EDE2E94D @default.
• Q37260574 P31 Q37260574-F75FA171-DFEA-41E3-A02B-022CF82A3132 @default.
• Q37260574 P356 Q37260574-11ACC770-357D-4387-9700-00B9BCF5E055 @default.
• Q37260574 P433 Q37260574-0E6DBBDF-6B7F-4F57-B8CB-95E9745B1D87 @default.
• Q37260574 P478 Q37260574-9C682E63-F54E-49BE-BEC7-CFB0185F7245 @default.
• Q37260574 P577 Q37260574-4E7DC00A-33B6-439F-86BE-D51EA9C0EA6A @default.
• Q37260574 P698 Q37260574-48E5F154-4082-40CB-9465-CF4F87CBEE7E @default.
• Q37260574 P921 Q37260574-1CE225C3-CC9F-4513-9187-0440E43B7145 @default.
• Q37260574 P932 Q37260574-A71DF3EF-AFAB-4733-B173-43B94AAC9D1A @default.
• Q37260574 P356 S00262-011-1123-2 @default.
• Q37260574 P698 22002243 @default.
• Q37260574 P1433 Q5031409 @default.
• Q37260574 P1476 "CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma" @default.
• Q37260574 P2093 "Haiyan Li" @default.
• Q37260574 P2093 "Jianfei Qian" @default.
• Q37260574 P2093 "Jing Yang" @default.
• Q37260574 P2093 "Qing Yi" @default.
• Q37260574 P2093 "Sungyoul Hong" @default.
• Q37260574 P2093 "Yong Lu" @default.
• Q37260574 P2093 "Yuhuan Zheng" @default.

• next